RxDoctor Payments DataLook up a doctor →

Robert Guilbault, MD

Family Medicine · Mandeville, LANPI 1275581092

Payments from drug & device makers

$17,386in general payments, 2019–2025

Across 994 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$988
  • plus $7K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$2,869
Amgen(2 entities)139$2,049
AstraZeneca78$1,699
Lilly USA, LLC89$1,469
Pfizer68$1,140
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC66$988
Boehringer Ingelheim49$926
Astellas Pharma US Inc34$694
Novo Nordisk51$677
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)23$487
Takeda Pharmaceuticals U.S.A., Inc.21$374
GSK20$353
Teva Pharmaceuticals USA, Inc.16$320
Sanofi-aventis U.S. LLC15$298
Biohaven Pharmaceutical Holding Company Ltd.14$283
Idorsia Pharmaceuticals US Inc18$271
Lundbeck LLC8$179
Supernus Pharmaceuticals, Inc.6$175
Axsome Therapeutics, Inc.7$169
Abbott3$166
Eisai Inc.10$165
Bayer7$156
Biohaven Pharmaceuticals, Inc.8$155
Noven Therapeutics, LLC7$134
Novartis5$104
Exact Sciences4$92
Johnson & Johnson6$92
Genentech USA, Inc.5$71
Sunovion Pharmaceuticals Inc.5$68
Corium, LLC3$63
Shire North American Group Inc3$57
Merck3$52
Dexcom, Inc.2$44
Neos Therapeutics, LP3$42
Kowa Pharmaceuticals America, Inc.3$41
Jazz Pharmaceuticals Inc.2$37
Smith+Nephew2$36
Alfasigma USA, Inc.2$33
Otsuka America Pharmaceutical, Inc.2$33
Adlon Therapeutics L.p.2$30
Clarus Therapeutics Inc.2$30
Philips North America LLC1$29
Sumitomo Pharma America, Inc.5$27
Kyowa Kirin, Inc.1$26
Tolmar, Inc.1$24
E.r. Squibb & Sons, L.L.C.1$21
Paratek Pharmaceuticals, Inc.1$20
Biogen1$19
Amneal Pharmaceuticals LLC1$19
Antares Pharma, Inc.1$18
Ironshore Pharmaceuticals Inc.1$17
Esperion Therapeutics, Inc.1$15
Amarin Pharma, Inc.1$14
Acerus Pharmaceuticals Corporation1$14

How this compares

$17,386 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$69,791
Medicare patients
245
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Mandeville

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →